Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.430
Neutral
RSI(14)
42.597
Neutral
STOCH(KDJ)(9,3,3)
17.734
Sell
ATR(14)
1.259
High Vlolatility
CCI(14)
-98.469
Neutral
Williams %R
71.881
Sell
TRIX(12,20)
0.037
Sell
StochRSI(14)
8.282
Oversold
QuidelOrtho Corp
QDEL26.990USD
+0.180+0.67%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
1.83BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of QuidelOrtho Corp
Currency: USD Updated: 2025-10-31Key Insights
The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
QuidelOrtho Corp's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Hold
Current Rating
40.167
Target Price
+49.82%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
QuidelOrtho Corp Highlights
StrengthsRisks
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Fairly Valued
The company’s latest PE is -3.95, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.57M shares, decreasing 21.40% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 42.00K shares of this stock.
Financial Health
Currency: USD Updated: 2025-10-31The company's current financial score is 6.39, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 613.90M, representing a year-over-year decrease of 3.63%, while its net profit experienced a year-over-year decrease of 72.92%.
Score
Financials
4.56
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.46
Operational Efficiency
6.90
Growth Potential
5.31
Shareholder Returns
7.73
QuidelOrtho Corp's Company Valuation
Currency: USD Updated: 2025-10-31The company’s current valuation score is 8.38, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -3.95, which is -339.74% below the recent high of 9.47 and -12415.41% above the recent low of -494.25.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 68/210
No Data
Earnings Forecast
Currency: USD Updated: 2025-10-31The company’s current earnings forecast score is 7.25, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for QuidelOrtho Corp is 34.00, with a high of 60.00 and a low of 26.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
8
analysts
Hold
Current Rating
40.167
Target Price
+49.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
89
Total
4
Median
7
Average
Company name
Ratings
Analysts
QuidelOrtho Corp
QDEL
8
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-10-31The company’s current price momentum score is 6.18, which is lower than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 30.07 and the support level at 24.70, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
27.882
Sell
MA10
28.835
Sell
MA20
28.214
Sell
MA50
28.447
Sell
MA100
27.814
Sell
MA200
31.419
Sell
Institutional Confidence
Currency: USD Updated: 2025-10-31The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 117.19%, representing a quarter-over-quarter increase of 1.35%. The largest institutional shareholder is The Vanguard, holding a total of 7.77M shares, representing 11.44% of shares outstanding, with 13.15% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
Rubric Capital Management LP
State Street Investment Management (US)
Fidelity Management & Research Company LLC
Dimensional Fund Advisors, L.P.
D. E. Shaw & Co., L.P.
American Century Investment Management, Inc.
AQR Capital Management, LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-10-31The company’s current risk assessment score is 5.42, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.34. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.34
VaR
+4.73%
240-Day Maximum Drawdown
+52.09%
240-Day Volatility
+57.88%
Return
Best Daily Return
60 days
+8.73%
120 days
+8.73%
5 years
+41.04%
Worst Daily Return
60 days
-6.40%
120 days
-8.65%
5 years
-32.20%
Sharpe Ratio
60 days
+1.32
120 days
-0.90
5 years
-0.51
Risk Assessment
Maximum Drawdown
240 days
+52.09%
3 years
+75.78%
5 years
+91.02%
Return-to-Drawdown Ratio
240 days
-0.59
3 years
-0.30
5 years
-0.19
Skewness
240 days
+3.54
3 years
+1.41
5 years
+0.62
Volatility
Realised Volatility
240 days
+57.88%
5 years
+52.86%
Standardised True Range
240 days
+6.19%
5 years
+13.23%
Downside Risk-Adjusted Return
120 days
-160.45%
240 days
-160.45%
Maximum Daily Upside Volatility
60 days
+40.95%
Maximum Daily Downside Volatility
60 days
+31.49%
Liquidity
Average Turnover Rate
60 days
+2.19%
120 days
+2.20%
5 years
--
Turnover Deviation
20 days
+31.95%
60 days
+41.25%
120 days
+41.87%
Peer Comparison
Healthcare Equipment & Supplies
QuidelOrtho Corp
QDEL
7.08 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
